SimVec-based hepatitis B vaccine

**SimVec-based hepatitis B vaccine** appears to refer to an experimental hepatitis B vaccine concept built on GeneCure's SimVec platform, a simian immunodeficiency virus based lentiviral gene-transfer system intended for vaccine development and other gene-delivery applications. Publicly accessible information identifies SimVec as a platform technology rather than a clearly named, discrete hepatitis B vaccine candidate, and the exact vaccine construct, antigen cassette, formulation, and clinical status for a hepatitis B specific product are not clearly described. Based on the platform description, the intended mechanism would be in vivo delivery and expression of hepatitis B viral antigen genes to induce adaptive immune responses, but the precise antigen target and product attributes are not publicly specified.